- ►annals.org [PDF] AT Chan, EL Giovannucci, ES Schernhammer, … - Annals of internal medicine, 2004 - Am Coll Physicians Background: Randomized, double-blind, placebo-controlled tri- als have
established that regular aspirin use reduces the risk for recurrent colorectal
adenoma. However, the effect of dose and duration of use, particularly in ... Cited by 88 - Related articles - BL Direct - All 8 versions
R Benamouzig, J Deyra, A Martin, B Girard, E … - Gastroenterology, 2003 - Elsevier Among the 238 patients who completed the year 1 colonoscopy, at least one
adenoma was observed in 38 patients of the 126 (30%) in the aspirin group and in
46 of the 112 (41%) in the placebo group; relative risk was 0.73 (95% ... Cited by 162 - Related articles - BL Direct - All 13 versions
JA Tangrea, PS Albert, E Lanza, K Woodson, D … - Cancer Causes and Control, 2003 - Springer Received 24 July 2002; accepted in revised form 9 January 2003 ... Key words:
adenomas, non-steroidal anti-inflammatory drugs, prospective, risk. ...
Objective: To prospectively examine the association between non-steroidal ... Cited by 38 - Related articles - BL Direct - All 5 versions
- ►oxfordjournals.org M Allison, C Garland, R Chlebowski, M Criqui, … - American journal of epidemiology, 2006 - Oxford Univ Press The purpose of this study was to test the hypothesis that aspirin use is
associated with a decreased risk of incident colorectal cancer. From the Women's
Health Initiative, 91,574 participants between the ages of 50 and 79 years ... Cited by 11 - Related articles - BL Direct - All 7 versions
- ►nih.gov AT Chan, EL Giovannucci, JA Meyerhardt, … - Jama, 2005 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 129 - Related articles - BL Direct - All 8 versions
AT Chan - Cancer Causes and Control, 2003 - Springer In this issue, Tangrea and colleagues add to the growing literature that aspirin
and other non-steroidal anti- inflammatory drugs (NSAIDs) are protective against
colorectal adenoma and cancer [1]. Their results stem from an analysis of ... Cited by 27 - Related articles - BL Direct - All 6 versions
- ►nih.gov AT Chan, EL Giovannucci, JA Meyerhardt, … - Gastroenterology, 2008 - Elsevier Background & Aims: Long-term data on the risk of colorectal cancer according to
dose, duration, and consistency of aspirin therapy are limited. Methods: We
conducted a prospective study of 47,363 male health professionals who were ... Cited by 24 - Related articles - All 28 versions
- ►pubget.com [PDF] RS Sandler, S Halabi, JA Baron, S Budinger, E … - New England Journal of Medicine, 2003 - content.nejm.org Methods We conducted a randomized, double-blind trial to determine the effect of
aspirin on the incidence of colorectal adenomas. We randomly assigned 635
patients with previous colorectal cancer to receive either 325 mg of ... Cited by 569 - Related articles - BL Direct - All 19 versions
- ►213.4.18.135 [PDF] LAG RodrÃguez, C Huerta-Alvarez - Epidemiology, 2000 - jstor.org Drugs: A Pooled Analysis of Published Studies and a ... Luis A. Garcia
Rodriguez and Consuelo Huerta-Alvarez ... (NSAIDs) has been associated with a
reduced risk of colorectal cancer, but less information is available on the ... Cited by 83 - Related articles - BL Direct - All 7 versions
C La Vecchia, E Negri, S Franceschi, E Conti, … - British journal of cancer, 1997 - pubmedcentral.nih.gov The relationship between aspirin use and colorectal cancer risk was examined by
a case-control study in Italy. Regular aspirin use was reported by only 47
(3.5%) cases and 77 (4.1%) control subjects, giving a multivariate odds ... Cited by 71 - Related articles - BL Direct - All 4 versions
